Purpose and objectives

The SN EN 17141:2021 standard establishes comprehensive requirements and methodologies for controlling biocontamination in cleanrooms and associated controlled environments. It aims to provide a structured framework for identifying, assessing, and managing microbiological contamination risks, ensuring that environments used in pharmaceuticals, medical devices, and biopharmaceuticals maintain the highest quality and safety standards. This standard is crucial for organizations striving to meet regulatory demands and enhance their overall contamination control systems.

Scope: who must comply

The SN EN 17141:2021 compliance requirements apply to a wide range of industries, particularly those involved in manufacturing pharmaceuticals, medical devices, and food products. Companies operating cleanrooms or controlled environments, such as hospitals and biopharma facilities, are directly affected by this standard. Compliance is essential for organizations concerned with environmental health and safety, as it addresses microbiological contamination risks that can impact product integrity and patient safety. Businesses must implement effective biocontamination control measures to align with these standards and avoid regulatory penalties.

How SN EN 17141:2021 relates to other standards

The SN EN 17141:2021 standard complements several other guidelines and standards, including:

• ISO 14698-1:2003: This standard provides guidelines for the assessment of biocontamination in cleanrooms and controlled environments, aligning with SN EN 17141:2021's objectives.
• ISO 14698-2:2003: This standard focuses on the validation of biocontamination control systems, ensuring that the methodologies outlined in SN EN 17141:2021 are effectively implemented.
• ISO 9001: This is a quality management standard that supports the overall framework for maintaining high-quality production processes, which includes biocontamination control practices.

Revision history and current status

The SN EN 17141:2021 standard was published by the European Committee for Standardization (CEN) in 2021, marking a significant update in the field of biocontamination control. This latest revision incorporates feedback from industry stakeholders and reflects advancements in cleanroom technology and microbiological control systems. Key changes in this revision include enhanced methodologies for risk assessment and environmental monitoring, aligning with current best practices in the industry.